InsiderTrades.com logo
Stephen Feider net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Stephen Feider Biography and Net Worth

CFO of Beta Bionics

In his role as CFO, Stephen is responsible for the finance, investor relations, human resources, customer service and IT organizations. His experience as a leader in the diabetes medical device industry began at Companion Medical, where the InPen system was first developed and launched to the US market. Medtronic acquired Companion Medical in 2020 and Stephen continued his career at Medtronic Diabetes. Prior to Companion Medical, Stephen worked as a CPA at PwC and Corporate Controller at Marathon Health. Stephen holds a Bachelors and Masters in Accountancy from Butler University.

What is Stephen Feider's net worth?

The estimated net worth of Stephen Feider is at least $600.43 thousand as of January 2nd, 2026. Feider owns 42,614 shares of Beta Bionics stock worth more than $600,431 as of February 4th. This net worth approximation does not reflect any other assets that Feider may own. Learn More about Stephen Feider's net worth.

How do I contact Stephen Feider?

The corporate mailing address for Feider and other Beta Bionics executives is 11 HUGHES, IRVINE, CA, 92618. Beta Bionics can also be reached via phone at (949) 427-7785 and via email at [email protected]. Learn More on Stephen Feider's contact information.

Has Stephen Feider been buying or selling shares of Beta Bionics?

During the past quarter, Stephen Feider has sold $590,600.00 in Beta Bionics stock. Most recently, Stephen Feider sold 20,000 shares of the business's stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $29.53, for a transaction totalling $590,600.00. Following the completion of the sale, the chief financial officer now directly owns 42,614 shares of the company's stock, valued at $1,258,391.42. Learn More on Stephen Feider's trading history.

Who are Beta Bionics' active insiders?

Beta Bionics' insider roster includes Stephen Feider (CFO), Mark Hopman (Insider), Mike Mensinger (Insider), and Steven Russell (Insider). Learn More on Beta Bionics' active insiders.

Are insiders buying or selling shares of Beta Bionics?

In the last twelve months, insiders at the sold shares 23 times. They sold a total of 108,722 shares worth more than $2,431,837.23. The most recent insider tranaction occured on January, 6th when insider Mike Mensinger sold 2,200 shares worth more than $66,220.00. Learn More about insider trades at Beta Bionics.

Information on this page was last updated on 1/6/2026.

Stephen Feider Insider Trading History at Beta Bionics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/2/2026Sell20,000$29.53$590,600.0042,614View SEC Filing Icon  
12/2/2025Sell1,427$29.34$41,868.1842,614View SEC Filing Icon  
10/3/2025Sell4,982$21.69$108,059.5844,041View SEC Filing Icon  
10/1/2025Sell15,018$20.76$311,773.6844,041View SEC Filing Icon  
9/5/2025Sell100$21.00$2,100.0044,041View SEC Filing Icon  
9/2/2025Sell1,462$18.86$27,573.3244,041View SEC Filing Icon  
8/22/2025Sell4,413$17.01$75,065.1345,503View SEC Filing Icon  
8/19/2025Sell5,587$17.03$95,146.6145,503View SEC Filing Icon  
6/2/2025Sell1,497$17.89$26,781.3345,503View SEC Filing Icon  
See Full Table

Stephen Feider Buying and Selling Activity at Beta Bionics

This chart shows Stephen Feider's buying and selling at Beta Bionics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Beta Bionics Company Overview

Beta Bionics logo
Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.
Read More

Today's Range

Now: $14.09
Low: $13.71
High: $14.95

50 Day Range

MA: $24.95
Low: $13.70
High: $31.99

2 Week Range

Now: $14.09
Low: $8.89
High: $32.71

Volume

1,464,576 shs

Average Volume

1,543,432 shs

Market Capitalization

$620.38 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A